Company news
Eco Animal Health Group Plc (LSE:EAH) news
Eco Animal Health Group Plc news releases on 6ix. Latest, Sep 17, 2026: USDA-CVB approves ECOVAXXIN® MS field safety data
Press releases & updates
USDA-CVB approves ECOVAXXIN® MS field safety data
September 17, 2026
Didier Branellec appointed Non-Executive Director
September 8, 2026
CEO and CFO Exercise of Options and RPT
August 19, 2026
Exclusive in-licensing agreement with Vaxinano
August 12, 2026
Director/PDMR Shareholding: CEO Share Purchase
July 16, 2026
Results for the year ended 31 March 2026
July 15, 2026
EU launch of ECOVAXXIN® MS
July 2, 2026
Renewal of revolving credit facility
June 4, 2026
Appointment of Head of Business Development
April 14, 2026
Board Change
March 31, 2026
Full Year Trading Update
March 19, 2026
ECOVAXXIN® MG favourable USDA safety assessment
March 11, 2026
Block Listing Return
March 5, 2026
EU launch plans for ECOVAXXIN® MS
February 26, 2026
Holding(s) in Company
January 19, 2026
ECOVAXXIN® MS EU marketing authorisation granted
December 22, 2025
Exercise of Share Options by Director
December 18, 2025
Director/PDMR Shareholding
December 4, 2025
Results for the six months ended 30 September 2025
December 1, 2025
Replacement: Notice of Results
November 20, 2025
EMA Positive Opinion Received for ECOVAXXIN® MS
November 10, 2025
Head of Global R&D
October 1, 2025
Result of AGM
September 25, 2025
Appointment of Joint Broker
September 1, 2025
Share Awards to Executive Directors
August 29, 2025
Posting of Annual Report and Notice of AGM
August 28, 2025
Result of General Meeting
August 21, 2025
Results for the year ended 31 March 2025
July 14, 2025
Notice of General Meeting and Notice of Results
July 8, 2025
Trading Update
April 24, 2025
R&D Day
March 13, 2025
Submission of Marketing Authorisation Application
March 3, 2025
Disposal of non-core assets
February 19, 2025
Block listing Interim Review
February 18, 2025
Notice of R&D Day
February 13, 2025
Board Changes
January 31, 2025
Share Purchase by Executive Director
December 2, 2024
Results for the Six Months Ended 30 September 2024
November 28, 2024
EBT Share Purchase
October 22, 2024
Issue of Equity and TVR
October 9, 2024
Deferred Share Option Award to Executive Directors
August 29, 2024
Posting of the Annual Report and Notice of AGM
August 16, 2024
Block Listing Interim Review
August 12, 2024
Final Results
July 15, 2024
Investor Presentation covering Full Year Results
July 12, 2024
Notice of Results
July 11, 2024
Risk Profile Demonstrated for ECOVAXXIN MS
May 8, 2024
Trading Update on year ended 31 March 2024
April 25, 2024
Disposal of non-core product line
April 4, 2024
Replacement: Trading Update
March 21, 2024